These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4190228)

  • 21. [Remote results of the treatment of patients with toxic goiter by radioactive iodine (I-131)].
    Petrova MM; Kurbatova LI
    Probl Endokrinol Gormonoter; 1965; 11(3):52-6. PubMed ID: 5898801
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reduced antithyroid agents as a result of radioiodine therapy?].
    Maka D; Schicha H; Körber C; Schneider P; Reiners C
    Nuklearmedizin; 2000; 39(2):N25-6. PubMed ID: 10768174
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dynamics of protein-bound iodine and iodine extracted with butanol in diffuse toxic goiter patients treated with radioactive iodine (I-131) after preliminary treatment with mercazolyl and reserpine].
    Anestiadi ZG
    Probl Endokrinol (Mosk); 1969; 15(1):6-10. PubMed ID: 4185484
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of Tc 99m-pertechnetate for the study inorganic iodine absorption by the thyroid gland under the effects of antithyroid preparations].
    Kotliarov EV; Budkevich IuB
    Med Radiol (Mosk); 1970 Jun; 15(6):55-8. PubMed ID: 4194224
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in the content of electrolytes under the effect of radioiodine therapy of patients with diffuse toxic goiter in association with a severe form of thyrotoxicosis].
    Lipets AI; Dozorets IL
    Med Radiol (Mosk); 1971 Sep; 16(9):23-6. PubMed ID: 5172424
    [No Abstract]   [Full Text] [Related]  

  • 26. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamics of serum lipid changes in patients with diffuse toxic goiter during treatment with I-131].
    Slukhaĭ IuF
    Med Radiol (Mosk); 1967 May; 12(5):67-9. PubMed ID: 5633311
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radioactive iodine treatment of patients with relapsing toxic goiter].
    Iaroslavtsev SA
    Klin Med (Mosk); 1968 Sep; 46(9):106-10. PubMed ID: 5756042
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the diagnosis and treatment of diseases of the thyroid gland with radioactive iodine].
    Egorov PI; Tsfasman AZ
    Ter Arkh; 1967 Mar; 39(3):5-9. PubMed ID: 4894050
    [No Abstract]   [Full Text] [Related]  

  • 30. [Some recent progress in the medical treatment of hyperthyroidism].
    Bricaire H; Joly J
    Presse Med (1893); 1967 Jun; 75(29):1517-21. PubMed ID: 4165247
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
    Véliz J; Pineda G; Arancibia P; Wohllk N
    Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complex treatment of toxic goiter].
    Kal'chenko II; Nechiporenko FP
    Sov Med; 1973 Oct; 36(10):99-102. PubMed ID: 4133131
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Criteria for recovery from diffuse toxic goiter].
    Baranov VG; Nikolaenko NF
    Klin Med (Mosk); 1970 Apr; 48(4):50-3. PubMed ID: 4193305
    [No Abstract]   [Full Text] [Related]  

  • 36. [Toxic adenoma. Study of 35 cases].
    Barceló Lucerga B; Alcañiz Ferrando J; Ortiz Berrocal J; Salto Hernández L
    Rev Iber Endocrinol; 1971; 18(106):369-83. PubMed ID: 5171341
    [No Abstract]   [Full Text] [Related]  

  • 37. Radioisotope therapy for Graves' disease.
    Goldsmith RE
    Mayo Clin Proc; 1972 Dec; 47(12):953-61. PubMed ID: 4564710
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term result of antithyroid drug therapy for Grave's disease: follow up after more than 5 years.
    Shizume K; Irie M; Nagataki S; Matsuzaki F; Shishiba Y
    Endocrinol Jpn; 1970 Oct; 17(5):327-32. PubMed ID: 4101380
    [No Abstract]   [Full Text] [Related]  

  • 39. [Functional condition of the liver in patients with diffuse toxic goiter before and after treatment by I-131].
    Siesivieva VG; Shlevkov BA; Belousova ND
    Med Radiol (Mosk); 1966 May; 11(5):21-7. PubMed ID: 6014327
    [No Abstract]   [Full Text] [Related]  

  • 40. [Megakaryocytopoiesis and thrombocytopoiesis in patients with diffuse toxic goiter during the period of treatment with I-131].
    Piksanov ON; Bykhovskaia AM
    Med Radiol (Mosk); 1967 Jan; 12(1):82-5. PubMed ID: 5633100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.